Sonoma Pharmaceuticals(DE:O8Z)
€2.690.00 (0.00%)
DE:O8Z
Sonoma Pharmaceuticals ownership
€2.69
At close:0.00 (0.00%)
Sonoma Pharmaceuticals (O8Z) Ownership - Who Owns Sonoma Pharmaceuticals?
1 Followers
Sonoma Pharmaceuticals (O8Z) Ownership Overview
- 7.38% Insiders
- 0.93% Mutual Funds
- 0.23% Other Institutional Investors
- 0.39% ETFs
- 91.06% Public Companies and Individual Investors
The ownership structure of Sonoma Pharmaceuticals (DE:O8Z) stock is a mix of institutional, retail, and individual investors. Approximately 1.55% of the company’s stock is owned by Institutional Investors, 7.38% is owned by Insiders, and 91.06% is owned by Public Companies and Individual Investors.
The ownership structure of Sonoma Pharmaceuticals (DE:O8Z) stock is a mix of institutional, retail, and individual investors. Approximately 1.55% of the company’s stock is owned by Institutional Investors, 7.38% is owned by Insiders, and 91.06% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Amy Moss Trombly | 153,586 | Insider | 3.21% | 458,761 |
| Jerome Dvonch | 84,595 | Insider | 1.77% | 252,685 |
| Jay Birnbaum | 51,659 | Insider | 1.08% | 154,305 |
| John Mclaughlin | 48,728 | Insider | 1.02% | 145,551 |
| Fidelity Concord Street Trust | 25,639 | Institution | 0.54% | 76,584 |
| Vanguard | 18,787 | Institution | 0.39% | 56,117 |
| Vanguard Index Funds | 18,787 | Institution | 0.39% | 56,117 |
| John Dal Poggetto | 15,000 | Insider | 0.31% | 44,805 |
| BlackRock, Inc. | 113 | Institution | <0.01% | 338 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Concord Street Trust | 25,639 | Institution | 0.54% | 76,584 |
| Vanguard Index Funds | 18,787 | Institution | 0.39% | 56,117 |
FAQ
Who Owns Sonoma Pharmaceuticals (DE:O8Z)?
According to the latest TipRanks data, approximately 1.55% of the company's stock is held by institutional investors, 7.38% is held by insiders, and 91.06% is held by public companies and individual investors.
What percentage of Sonoma Pharmaceuticals (DE:O8Z) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.55% of Sonoma Pharmaceuticals (DE:O8Z) stock is held by institutional investors: 0.93% by mutual funds, 0.39% by ETFs and 0.23% by other institutional investors.
What percentage of Sonoma Pharmaceuticals (DE:O8Z) stock is held by retail investors?
According to the latest TipRanks data, approximately 91.06% of Sonoma Pharmaceuticals (DE:O8Z) stock is held by public companies and individual investors.
Who owns the most shares of Sonoma Pharmaceuticals (DE:O8Z)?
Amy Moss Trombly owns the most shares of Sonoma Pharmaceuticals (DE:O8Z).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
